about
Clinical significance of T cell metabolic reprogramming in cancerImmunotherapies for malignant glioma.The adaptor molecule RIAM integrates signaling events critical for integrin-mediated control of immune function and cancer progression.Feeling stressed? It might be your T cells.Possible reactivation of chromosomally integrated human herpesvirus 6 after treatment with histone deacetylase inhibitorInteraction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activationAssessment of a multi-cytokine profile by a novel biochip-based assay allows correlation of cytokine profiles with clinical outcomes in adult recipients of umbilical cord blood transplantationA secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppressionA phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiationPhosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cellsTargeted deletion of PD-1 in myeloid cells induces antitumor immunity
P50
Q26741974-F91460AE-A712-4DDA-97ED-29CFF633593AQ47915209-0C3FB642-D735-47B5-A2A9-F9C97F881A9AQ47919378-8B75FC89-DA72-4F03-8FCF-01CB092FC73EQ48291509-ED4A5A5A-9D1B-4BAA-861F-CCC3F361A39BQ89092987-9CE8249E-6B2F-438E-BE5E-0EB3722D2251Q90408578-362B2FC3-6512-43A6-ADC3-0A4477D2F508Q90441813-796BC158-23EE-422E-92BC-B94512137BC7Q90626097-016C9FE4-FA21-413A-BEC2-51B01EFBB7FAQ90731240-08E46406-AFEB-4842-BA30-76C1993E257FQ91386275-36E8EAE6-7173-4E83-AA5D-4FA554D527B6Q92412004-EF3F2D98-BBE0-4646-8E86-3C4F42356504
P50
description
researcher
@en
name
Vassiliki A Boussiotis
@en
type
label
Vassiliki A Boussiotis
@en
prefLabel
Vassiliki A Boussiotis
@en
P31
P496
0000-0002-3963-1518